Authors:
Mollica, RH
Sarajlic, N
Chernoff, M
Lavelle, J
Vukovic, IS
Massagli, MP
Citation: Rh. Mollica et al., Longitudinal study of psychiatric symptoms, disability, mortality, and emigration among Bosnian refugees, J AM MED A, 286(5), 2001, pp. 546-554
Authors:
Aweeka, F
Trapnell, C
Chernoff, M
Jayewardene, A
Spritzler, J
Bellibas, SE
Lizak, P
Jacobson, J
Citation: F. Aweeka et al., Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251, J CLIN PHAR, 41(10), 2001, pp. 1091-1097
Authors:
Jacobson, JM
Greenspan, JS
Spritzler, J
Fox, L
Fahey, JL
Jackson, JB
Chernoff, M
Wohl, DA
Pulvirenti, JJ
Hooton, TM
Shikuma, C
Citation: Jm. Jacobson et al., Thalidomide in low intermittent doses does not prevent recurrence of humanimmunodeficiency virus-associated aphthous ulcers, J INFEC DIS, 183(2), 2001, pp. 343-346
Authors:
Reimann, KA
Chernoff, M
Wilkening, CL
Nickerson, CE
Landay, AL
Citation: Ka. Reimann et al., Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: Implications for multicenter clinical trials, CL DIAG LAB, 7(3), 2000, pp. 352-359
Authors:
Jacobson, JM
Spritzler, J
Fox, L
Fahey, JL
Jackson, JB
Chernoff, M
Wohl, DA
Wu, AW
Hooton, TM
Sha, BE
Shikuma, CM
MacPhail, LA
Simpson, DM
Trapnell, CB
Basgoz, N
Citation: Jm. Jacobson et al., Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection, J INFEC DIS, 180(1), 1999, pp. 61-67